Endocrine Cancer
Conference Coverage
Surgery has edge over surveillance for micropapillary thyroid cancer
BALTIMORE – Endocrinologists and surgeons need to have in-depth conversations with their patients to determine their level of anxiety about having...
Conference Coverage
VIDEO: Proposed revision of medullary thyroid cancer staging improves risk-stratification analysis
BOSTON – An analysis of data from medullary thyroid cancer patients that partitioned the patients into groups with similar overall survival has...
News
Adjuvant endocrine therapy for premenopausal breast cancer patients should be individualized
Key clinical point: Decisions about adjuvant endocrine therapies in premenopausal women with HR–positive, HER2-negative early breast cancer should...
Conference Coverage
Early biopsy predicts levonorgestrel IUD response in endometrial cancer
Endometrial pathology findings at 3 months predicted response to levonorgestrel-releasing IUD treatment for complex atypical hyperplasia or grade...
Conference Coverage
A call for definitive trial of statins in breast cancer
Observational evidence from studies with large patient numbers suggests statin therapy during treatment for breast cancer may protect against...
Conference Coverage
ITC: Study provides first evidence of paclitaxel benefit for anaplastic thyroid cancer
Weekly infusions of paclitaxel delayed progression in some patients with the very aggressive anaplastic thyroid cancer, a small prospective study...
Conference Coverage
Increased surveillance may explain post-Fukushima pediatric thyroid cancers
The increased incidence of thyroid cancers in Japanese youth after the Fukushima nuclear accident may be an artifact of increased surveillance.
News
RFA, ethanol ablation equally effective for thyroid nodules
Key clinical point: Radiofrequency ablation and ethanol ablation were similarly effective in treating cystic thyroid nodules. Major finding: At 6...
News
Moderate THST was most effective at treating thyroid cancer
In all stages of thyroid cancer, moderate THST was associated with significantly improved overall survival and disease-free survival.
Conference Coverage
AACE: How to safely skip radioactive iodine for low-grade thyroid cancer
Key clinical point: Thyroid cancer patients do not need radioactive iodine treatment if their nonsuppressed thyroglobulin is less than 2 ng/mL 2...